Last quarter (Q4 2022), AFT Pharmaceuticals Ltd.'s total revenue was $―, a decrease of ― from previous quarter. In Q4, AFT Pharmaceuticals Ltd.'s net income was $―. See AFT Pharmaceuticals Ltd.’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Mar 22	Mar 21	Mar 20	Mar 19
Total Revenue	-	$ 129.83M	$ 113.11M	$ 105.60M	$ 85.13M
Cost of Revenue	-	$ 68.54M	$ 64.36M	$ 57.33M	$ 44.40M
Gross Profit	-	$ 61.30M	$ 48.74M	$ 48.27M	$ 40.73M
Operating Expense	-	$ 42.66M	$ 39.76M	$ 38.08M	$ 36.33M
Operating Income	-	$ 18.64M	$ 8.98M	$ 10.19M	$ 4.40M
Net Non Operating Interest Income Expense	-	$ -2.43M	$ -3.44M	$ -8.33M	$ -8.38M
Other Income Expense	-	$ 1.43M	$ 1.24M	$ 10.24M	$ 1.72M
Pretax Income	-	$ 18.68M	$ 7.89M	$ 12.88M	$ -2.26M
Tax Provision	-	$ -1.16M	$ 105.00K	$ 185.00K	$ 168.00K
Earnings From Equity Interest Net Of Tax	-	-	-	-	-
Net Income Common Stockholders	-	$ 19.85M	$ 7.78M	$ 12.69M	$ -2.43M
Basic EPS	-	$ 0.19	$ 0.08	$ 0.13	$ -0.02
Diluted EPS	-	$ 0.19	$ 0.08	$ 0.13	$ -0.02
Basic Average Shares	-	$ 104.68M	$ 103.30M	$ 97.31M	$ 97.31M
Diluted Average Shares	-	$ 104.68M	$ 103.30M	$ 97.31M	$ 97.31M
Dividend Per Share	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-
Total Expenses	-	-	-	-	-
Net Income From Continuing And Discontinued Operation	-	$ 19.85M	$ 7.78M	$ 12.69M	$ -2.43M
Normalized Income	-	$ 19.85M	$ 7.78M	$ 12.69M	$ -2.43M
Interest Expense	-	$ 2.44M	$ 3.44M	$ 8.05M	$ 8.42M
EBIT	-	$ 21.12M	$ 11.33M	$ 20.93M	$ 6.16M
EBITDA	-	$ 22.16M	$ 12.43M	$ 21.71M	$ 6.16M

Currency in NZD

AFT Pharmaceuticals Ltd. Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing